nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—TUBB4B—Docetaxel—pancreatic cancer	0.325	0.338	CbGbCtD
Mebendazole—CYP1A1—Dacarbazine—pancreatic cancer	0.132	0.138	CbGbCtD
Mebendazole—CYP1A1—Tamoxifen—pancreatic cancer	0.105	0.11	CbGbCtD
Mebendazole—CYP1A1—Erlotinib—pancreatic cancer	0.0895	0.0931	CbGbCtD
Mebendazole—ABCB1—Tamoxifen—pancreatic cancer	0.0411	0.0428	CbGbCtD
Mebendazole—ABCB1—Gemcitabine—pancreatic cancer	0.0354	0.0369	CbGbCtD
Mebendazole—ABCB1—Erlotinib—pancreatic cancer	0.035	0.0364	CbGbCtD
Mebendazole—ABCB1—Irinotecan—pancreatic cancer	0.0316	0.0329	CbGbCtD
Mebendazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0246	0.0256	CbGbCtD
Mebendazole—ABCB1—Docetaxel—pancreatic cancer	0.0231	0.0241	CbGbCtD
Mebendazole—ABCB1—Sunitinib—pancreatic cancer	0.023	0.024	CbGbCtD
Mebendazole—CYP3A4—Erlotinib—pancreatic cancer	0.021	0.0218	CbGbCtD
Mebendazole—CYP3A4—Irinotecan—pancreatic cancer	0.0189	0.0197	CbGbCtD
Mebendazole—ABCB1—Doxorubicin—pancreatic cancer	0.0173	0.0179	CbGbCtD
Mebendazole—CYP3A4—Docetaxel—pancreatic cancer	0.0139	0.0144	CbGbCtD
Mebendazole—CYP3A4—Sunitinib—pancreatic cancer	0.0138	0.0144	CbGbCtD
Mebendazole—CYP3A4—Doxorubicin—pancreatic cancer	0.0103	0.0108	CbGbCtD
Mebendazole—TUBA1A—Zalcitabine—Gemcitabine—pancreatic cancer	0.00632	0.826	CbGdCrCtD
Mebendazole—TUBA1A—gall bladder—pancreatic cancer	0.00193	0.246	CbGeAlD
Mebendazole—TUBA1A—Azacitidine—Gemcitabine—pancreatic cancer	0.00133	0.174	CbGdCrCtD
Mebendazole—Ketoprofen—CXCL8—pancreatic cancer	0.00128	0.271	CrCbGaD
Mebendazole—TUBA1A—islet of Langerhans—pancreatic cancer	0.00127	0.161	CbGeAlD
Mebendazole—Ketorolac—PTGS2—pancreatic cancer	0.00119	0.251	CrCbGaD
Mebendazole—Tiaprofenic acid—PTGS2—pancreatic cancer	0.000967	0.205	CrCbGaD
Mebendazole—Nepafenac—PTGS2—pancreatic cancer	0.00092	0.195	CrCbGaD
Mebendazole—TUBA1A—pancreas—pancreatic cancer	0.00089	0.113	CbGeAlD
Mebendazole—TUBB4B—islet of Langerhans—pancreatic cancer	0.000843	0.108	CbGeAlD
Mebendazole—TUBA1A—digestive system—pancreatic cancer	0.00076	0.0968	CbGeAlD
Mebendazole—TUBB4B—pancreas—pancreatic cancer	0.000593	0.0756	CbGeAlD
Mebendazole—TUBB4B—digestive system—pancreatic cancer	0.000506	0.0645	CbGeAlD
Mebendazole—TUBA1A—p73 transcription factor network—HEY2—pancreatic cancer	0.000484	0.0434	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—WT1—pancreatic cancer	0.000417	0.0373	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—JAG2—pancreatic cancer	0.000398	0.0356	CbGpPWpGaD
Mebendazole—TUBA1A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	0.00039	0.035	CbGpPWpGaD
Mebendazole—Ketoprofen—PTGS2—pancreatic cancer	0.000373	0.0789	CrCbGaD
Mebendazole—TUBA1A—G2/M Transition—FOXM1—pancreatic cancer	0.000337	0.0302	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	0.000332	0.0297	CbGpPWpGaD
Mebendazole—TUBA1A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	0.00033	0.0295	CbGpPWpGaD
Mebendazole—CYP1A1—digestive system—pancreatic cancer	0.000284	0.0361	CbGeAlD
Mebendazole—Neutropenia—Tamoxifen—pancreatic cancer	0.000278	0.0382	CcSEcCtD
Mebendazole—Neutropenia—Erlotinib—pancreatic cancer	0.000275	0.0378	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle—SYCP1—pancreatic cancer	0.00027	0.0242	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—BRCA2—pancreatic cancer	0.000246	0.022	CbGpPWpGaD
Mebendazole—ABCB1—islet of Langerhans—pancreatic cancer	0.000245	0.0313	CbGeAlD
Mebendazole—Neutropenia—Sunitinib—pancreatic cancer	0.000238	0.0327	CcSEcCtD
Mebendazole—Hepatitis—Tamoxifen—pancreatic cancer	0.000238	0.0327	CcSEcCtD
Mebendazole—Hepatitis—Erlotinib—pancreatic cancer	0.000236	0.0323	CcSEcCtD
Mebendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	0.000236	0.0211	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000211	0.0189	CbGpPWpGaD
Mebendazole—CYP3A4—digestive system—pancreatic cancer	0.000208	0.0265	CbGeAlD
Mebendazole—CYP1A1—Oxidative Stress—NFE2L2—pancreatic cancer	0.000208	0.0186	CbGpPWpGaD
Mebendazole—Hepatitis—Sunitinib—pancreatic cancer	0.000204	0.028	CcSEcCtD
Mebendazole—TUBB4B—G2/M Transition—FOXM1—pancreatic cancer	0.000203	0.0182	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	0.0002	0.018	CbGpPWpGaD
Mebendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	0.000199	0.0178	CbGpPWpGaD
Mebendazole—Neutropenia—Irinotecan—pancreatic cancer	0.000196	0.0269	CcSEcCtD
Mebendazole—Neutropenia—Gemcitabine—pancreatic cancer	0.000191	0.0262	CcSEcCtD
Mebendazole—Angioedema—Tamoxifen—pancreatic cancer	0.00019	0.026	CcSEcCtD
Mebendazole—ABCB1—pancreas—pancreatic cancer	0.000172	0.022	CbGeAlD
Mebendazole—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00017	0.0233	CcSEcCtD
Mebendazole—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000167	0.0229	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle—SYCP1—pancreatic cancer	0.000163	0.0146	CbGpPWpGaD
Mebendazole—Angioedema—Sunitinib—pancreatic cancer	0.000162	0.0223	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—FUT8—pancreatic cancer	0.00016	0.0144	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—RB1—pancreatic cancer	0.000158	0.0142	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	0.000156	0.0139	CbGpPWpGaD
Mebendazole—Convulsion—Sunitinib—pancreatic cancer	0.000154	0.0211	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.000151	0.0136	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.000151	0.0136	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000149	0.0134	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000148	0.0132	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000148	0.0132	CbGpPWpGaD
Mebendazole—ABCB1—digestive system—pancreatic cancer	0.000147	0.0188	CbGeAlD
Mebendazole—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000138	0.019	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle—RBBP8—pancreatic cancer	0.000138	0.0124	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000137	0.0188	CcSEcCtD
Mebendazole—Neutropenia—Docetaxel—pancreatic cancer	0.000136	0.0186	CcSEcCtD
Mebendazole—Urticaria—Tamoxifen—pancreatic cancer	0.000135	0.0184	CcSEcCtD
Mebendazole—Abdominal pain—Tamoxifen—pancreatic cancer	0.000134	0.0183	CcSEcCtD
Mebendazole—Abdominal pain—Erlotinib—pancreatic cancer	0.000132	0.0181	CcSEcCtD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000127	0.0114	CbGpPWpGaD
Mebendazole—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000125	0.0171	CcSEcCtD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000122	0.0109	CbGpPWpGaD
Mebendazole—Convulsion—Fluorouracil—pancreatic cancer	0.000121	0.0166	CcSEcCtD
Mebendazole—Agranulocytosis—Docetaxel—pancreatic cancer	0.000121	0.0166	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.00012	0.0108	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000119	0.0163	CcSEcCtD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000117	0.0104	CbGpPWpGaD
Mebendazole—Hepatitis—Docetaxel—pancreatic cancer	0.000116	0.0159	CcSEcCtD
Mebendazole—CYP1A1—Oxidative Stress—SOD2—pancreatic cancer	0.000116	0.0104	CbGpPWpGaD
Mebendazole—Abdominal pain—Sunitinib—pancreatic cancer	0.000115	0.0157	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle—PPP2R5B—pancreatic cancer	0.000107	0.00963	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000107	0.0096	CbGpPWpGaD
Mebendazole—Hypersensitivity—Sunitinib—pancreatic cancer	0.000107	0.0146	CcSEcCtD
Mebendazole—Rash—Tamoxifen—pancreatic cancer	0.000107	0.0146	CcSEcCtD
Mebendazole—Dermatitis—Tamoxifen—pancreatic cancer	0.000107	0.0146	CcSEcCtD
Mebendazole—Rash—Erlotinib—pancreatic cancer	0.000106	0.0145	CcSEcCtD
Mebendazole—Dermatitis—Erlotinib—pancreatic cancer	0.000106	0.0145	CcSEcCtD
Mebendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—pancreatic cancer	9.88e-05	0.00885	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—PCSK1—pancreatic cancer	9.79e-05	0.00877	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Irinotecan—pancreatic cancer	9.77e-05	0.0134	CcSEcCtD
Mebendazole—CYP1A1—Melatonin metabolism and effects—APOE—pancreatic cancer	9.73e-05	0.00872	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—FUT8—pancreatic cancer	9.68e-05	0.00867	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—FOXM1—pancreatic cancer	9.58e-05	0.00858	CbGpPWpGaD
Mebendazole—Abdominal pain—Irinotecan—pancreatic cancer	9.44e-05	0.0129	CcSEcCtD
Mebendazole—TUBA1A—p73 transcription factor network—MYC—pancreatic cancer	9.44e-05	0.00846	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	9.4e-05	0.00842	CbGpPWpGaD
Mebendazole—Neutropenia—Epirubicin—pancreatic cancer	9.16e-05	0.0126	CcSEcCtD
Mebendazole—Rash—Sunitinib—pancreatic cancer	9.14e-05	0.0125	CcSEcCtD
Mebendazole—Dermatitis—Sunitinib—pancreatic cancer	9.14e-05	0.0125	CcSEcCtD
Mebendazole—Urticaria—Fluorouracil—pancreatic cancer	9.09e-05	0.0125	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—PPP2R5B—pancreatic cancer	8.96e-05	0.00803	CbGpPWpGaD
Mebendazole—Hypersensitivity—Irinotecan—pancreatic cancer	8.8e-05	0.0121	CcSEcCtD
Mebendazole—Convulsion—Docetaxel—pancreatic cancer	8.77e-05	0.012	CcSEcCtD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	8.53e-05	0.00764	CbGpPWpGaD
Mebendazole—Neutropenia—Doxorubicin—pancreatic cancer	8.47e-05	0.0116	CcSEcCtD
Mebendazole—Hypersensitivity—Fluorouracil—pancreatic cancer	8.43e-05	0.0116	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle—RBBP8—pancreatic cancer	8.34e-05	0.00748	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	8.23e-05	0.00737	CbGpPWpGaD
Mebendazole—Agranulocytosis—Epirubicin—pancreatic cancer	8.15e-05	0.0112	CcSEcCtD
Mebendazole—Hepatitis—Epirubicin—pancreatic cancer	7.84e-05	0.0107	CcSEcCtD
Mebendazole—Agranulocytosis—Doxorubicin—pancreatic cancer	7.54e-05	0.0103	CcSEcCtD
Mebendazole—Rash—Irinotecan—pancreatic cancer	7.53e-05	0.0103	CcSEcCtD
Mebendazole—Dermatitis—Irinotecan—pancreatic cancer	7.53e-05	0.0103	CcSEcCtD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	7.37e-05	0.00661	CbGpPWpGaD
Mebendazole—Rash—Gemcitabine—pancreatic cancer	7.34e-05	0.0101	CcSEcCtD
Mebendazole—Dermatitis—Gemcitabine—pancreatic cancer	7.33e-05	0.01	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	7.26e-05	0.0065	CbGpPWpGaD
Mebendazole—Hepatitis—Doxorubicin—pancreatic cancer	7.25e-05	0.00994	CcSEcCtD
Mebendazole—Rash—Fluorouracil—pancreatic cancer	7.21e-05	0.00989	CcSEcCtD
Mebendazole—Dermatitis—Fluorouracil—pancreatic cancer	7.21e-05	0.00988	CcSEcCtD
Mebendazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.75e-05	0.00925	CcSEcCtD
Mebendazole—Abdominal pain—Docetaxel—pancreatic cancer	6.53e-05	0.00895	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle—PPP2R5B—pancreatic cancer	6.49e-05	0.00581	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	6.47e-05	0.00579	CbGpPWpGaD
Mebendazole—Hypersensitivity—Docetaxel—pancreatic cancer	6.08e-05	0.00834	CcSEcCtD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.96e-05	0.00534	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—PCSK1—pancreatic cancer	5.91e-05	0.0053	CbGpPWpGaD
Mebendazole—Convulsion—Epirubicin—pancreatic cancer	5.91e-05	0.0081	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle—FOXM1—pancreatic cancer	5.78e-05	0.00518	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	5.61e-05	0.00503	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	5.58e-05	0.005	CbGpPWpGaD
Mebendazole—Convulsion—Doxorubicin—pancreatic cancer	5.47e-05	0.0075	CcSEcCtD
Mebendazole—TUBB4B—Metabolism of proteins—PPP2R5B—pancreatic cancer	5.41e-05	0.00485	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	5.36e-05	0.0048	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—BRCA2—pancreatic cancer	5.25e-05	0.0047	CbGpPWpGaD
Mebendazole—Rash—Docetaxel—pancreatic cancer	5.21e-05	0.00714	CcSEcCtD
Mebendazole—Dermatitis—Docetaxel—pancreatic cancer	5.2e-05	0.00713	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—GCG—pancreatic cancer	5.14e-05	0.00461	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	5.06e-05	0.00453	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	5.04e-05	0.00452	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TYMS—pancreatic cancer	4.99e-05	0.00447	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	4.61e-05	0.00413	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.6e-05	0.00413	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.55e-05	0.00624	CcSEcCtD
Mebendazole—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	4.54e-05	0.00407	CbGpPWpGaD
Mebendazole—Urticaria—Epirubicin—pancreatic cancer	4.42e-05	0.00606	CcSEcCtD
Mebendazole—Abdominal pain—Epirubicin—pancreatic cancer	4.4e-05	0.00603	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle—TERT—pancreatic cancer	4.35e-05	0.0039	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	4.31e-05	0.00386	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	4.31e-05	0.00386	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.21e-05	0.00578	CcSEcCtD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	4.12e-05	0.0037	CbGpPWpGaD
Mebendazole—Hypersensitivity—Epirubicin—pancreatic cancer	4.1e-05	0.00562	CcSEcCtD
Mebendazole—Urticaria—Doxorubicin—pancreatic cancer	4.09e-05	0.00561	CcSEcCtD
Mebendazole—Abdominal pain—Doxorubicin—pancreatic cancer	4.07e-05	0.00558	CcSEcCtD
Mebendazole—Hypersensitivity—Doxorubicin—pancreatic cancer	3.8e-05	0.0052	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RB1—pancreatic cancer	3.78e-05	0.00339	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	3.77e-05	0.00338	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	3.73e-05	0.00334	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	3.73e-05	0.00334	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	3.7e-05	0.00332	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	3.67e-05	0.00329	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	3.63e-05	0.00325	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	3.59e-05	0.00321	CbGpPWpGaD
Mebendazole—Rash—Epirubicin—pancreatic cancer	3.51e-05	0.00481	CcSEcCtD
Mebendazole—Dermatitis—Epirubicin—pancreatic cancer	3.51e-05	0.00481	CcSEcCtD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	3.39e-05	0.00303	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RB1—pancreatic cancer	3.38e-05	0.00303	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—TYMS—pancreatic cancer	3.37e-05	0.00302	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	3.34e-05	0.003	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	3.34e-05	0.00299	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	3.33e-05	0.00299	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	3.33e-05	0.00298	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	3.27e-05	0.00293	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	3.27e-05	0.00293	CbGpPWpGaD
Mebendazole—Rash—Doxorubicin—pancreatic cancer	3.25e-05	0.00445	CcSEcCtD
Mebendazole—Dermatitis—Doxorubicin—pancreatic cancer	3.25e-05	0.00445	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle—BRCA2—pancreatic cancer	3.17e-05	0.00284	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	3.11e-05	0.00279	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.11e-05	0.00279	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—GCG—pancreatic cancer	3.11e-05	0.00278	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.09e-05	0.00277	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TYMS—pancreatic cancer	3.01e-05	0.0027	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—pancreatic cancer	2.97e-05	0.00267	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	2.92e-05	0.00262	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—pancreatic cancer	2.92e-05	0.00261	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	2.87e-05	0.00257	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	2.86e-05	0.00256	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	2.81e-05	0.00252	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP2—pancreatic cancer	2.71e-05	0.00242	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TERT—pancreatic cancer	2.63e-05	0.00235	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.62e-05	0.00235	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	2.54e-05	0.00227	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND1—pancreatic cancer	2.51e-05	0.00225	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.46e-05	0.0022	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	2.32e-05	0.00208	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RB1—pancreatic cancer	2.29e-05	0.00205	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—pancreatic cancer	2.25e-05	0.00202	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CXCL8—pancreatic cancer	2.25e-05	0.00201	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	2.22e-05	0.00199	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	2.22e-05	0.00199	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	2.17e-05	0.00195	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.15e-05	0.00193	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	2.12e-05	0.0019	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CTNNB1—pancreatic cancer	2.07e-05	0.00186	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RB1—pancreatic cancer	2.04e-05	0.00183	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—pancreatic cancer	2.02e-05	0.00181	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	2.01e-05	0.0018	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	1.97e-05	0.00176	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	1.88e-05	0.00169	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—pancreatic cancer	1.8e-05	0.00161	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	1.73e-05	0.00155	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.7e-05	0.00152	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—pancreatic cancer	1.66e-05	0.00148	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP2—pancreatic cancer	1.63e-05	0.00146	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.61e-05	0.00145	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.6e-05	0.00144	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.54e-05	0.00138	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—pancreatic cancer	1.52e-05	0.00136	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PRSS1—pancreatic cancer	1.44e-05	0.00129	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.4e-05	0.00125	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.39e-05	0.00124	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.36e-05	0.00122	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CXCL8—pancreatic cancer	1.36e-05	0.00122	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CTNNB1—pancreatic cancer	1.25e-05	0.00112	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ARG2—pancreatic cancer	1.25e-05	0.00112	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—pancreatic cancer	1.22e-05	0.00109	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.18e-05	0.00106	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.15e-05	0.00103	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.09e-05	0.000981	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TYMP—pancreatic cancer	1.09e-05	0.000977	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.07e-05	0.000955	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.06e-05	0.000945	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.03e-05	0.000921	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—pancreatic cancer	1e-05	0.000896	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ARG2—pancreatic cancer	9.96e-06	0.000893	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	9.54e-06	0.000854	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	9.29e-06	0.000832	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9e-06	0.000806	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GLP1R—pancreatic cancer	8.79e-06	0.000787	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TYMP—pancreatic cancer	8.71e-06	0.00078	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—DPYD—pancreatic cancer	8.65e-06	0.000775	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	8.55e-06	0.000766	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	8.52e-06	0.000764	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	8.36e-06	0.000749	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	8.2e-06	0.000735	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.12e-06	0.000727	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.96e-06	0.000713	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.9e-06	0.000707	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.84e-06	0.000702	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	7.25e-06	0.00065	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.14e-06	0.00064	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.08e-06	0.000634	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GLP1R—pancreatic cancer	7.02e-06	0.000629	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	7.02e-06	0.000629	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—DPYD—pancreatic cancer	6.91e-06	0.000619	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC2A2—pancreatic cancer	6.55e-06	0.000587	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CD44—pancreatic cancer	6.35e-06	0.000569	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.22e-06	0.000557	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.16e-06	0.000552	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.14e-06	0.00055	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GCG—pancreatic cancer	6.09e-06	0.000546	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.93e-06	0.000531	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—STK11—pancreatic cancer	5.73e-06	0.000513	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.38e-06	0.000482	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.36e-06	0.000481	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CD44—pancreatic cancer	5.07e-06	0.000455	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TYMS—pancreatic cancer	4.93e-06	0.000441	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCG—pancreatic cancer	4.87e-06	0.000436	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—STK11—pancreatic cancer	4.57e-06	0.00041	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.32e-06	0.000387	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.25e-06	0.000381	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.04e-06	0.000362	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOE—pancreatic cancer	4.01e-06	0.000359	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TYMS—pancreatic cancer	3.93e-06	0.000353	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.79e-06	0.00034	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	3.62e-06	0.000324	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—pancreatic cancer	3.49e-06	0.000313	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOE—pancreatic cancer	3.2e-06	0.000287	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	3.18e-06	0.000285	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CD44—pancreatic cancer	3.13e-06	0.00028	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCG—pancreatic cancer	3e-06	0.000269	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.89e-06	0.000259	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—STK11—pancreatic cancer	2.82e-06	0.000253	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—pancreatic cancer	2.79e-06	0.00025	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	2.77e-06	0.000248	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—pancreatic cancer	2.75e-06	0.000246	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.54e-06	0.000227	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.42e-06	0.000217	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.39e-06	0.000215	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.21e-06	0.000198	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.19e-06	0.000196	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOE—pancreatic cancer	1.97e-06	0.000177	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTEN—pancreatic cancer	1.91e-06	0.000171	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.78e-06	0.000159	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.72e-06	0.000154	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.69e-06	0.000151	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.56e-06	0.00014	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.38e-06	0.000124	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.36e-06	0.000122	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.35e-06	0.000121	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.35e-06	0.000121	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.18e-06	0.000106	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—pancreatic cancer	1.1e-06	9.87e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.31e-07	7.45e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.79e-07	6.08e-05	CbGpPWpGaD
